{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:45:45Z","timestamp":1791405945183,"version":"4.3.3"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"DOI":"10.1093\/hmg\/ddv023","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T00:49:45Z","timestamp":1422060585000},"page":"2604-2614","source":"Crossref","is-referenced-by-count":59,"title":["A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits"],"prefix":"10.1093","volume":"24","author":[{"given":"Israel","family":"Aharony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar E.","family":"Ehrnhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Shruster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Offen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"key\n\t\t\t\t20170503081409_DDV023C1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"key\n\t\t\t\t20170503081409_DDV023C2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","article-title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract","volume":"13","author":"Goldberg","year":"1996","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C3","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503081409_DDV023C4","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2010","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503081409_DDV023C5","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","article-title":"Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus","volume":"17","author":"Warby","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/ddt458","article-title":"p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin","volume":"23","author":"Ehrnhoefer","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170503081409_DDV023C8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170503081409_DDV023C9","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/hmg\/ddr176","article-title":"Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative","volume":"20","author":"Tebbenkamp","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t20170503081409_DDV023C11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2736(01)00398-4","article-title":"Cargo delivery kinetics of cell-penetrating peptides","volume":"1515","author":"H\u00e4llbrink","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170503081409_DDV023C12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0006-291X(03)01135-5","article-title":"Uptake of analogs of penetratin, TAT(48\u201360) and oligoarginine in live cells","volume":"307","author":"Thor\u00e9n","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170503081409_DDV023C13","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1021\/bi020593l","article-title":"Structural and functional analysis of caspase active sites","volume":"42","author":"Ch\u00e9reau","year":"2003","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170503081409_DDV023C14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.chembiol.2010.08.014","article-title":"Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models","volume":"17","author":"Leyva","year":"2010","journal-title":"Chem. Biol."},{"key":"key\n\t\t\t\t20170503081409_DDV023C15","doi-asserted-by":"crossref","first-page":"15188","DOI":"10.1073\/pnas.232473399","article-title":"Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation","volume":"99","author":"Le","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170503081409_DDV023C16","article-title":"Partial rescue of some features of Huntington disease in the genetic absence of caspase-6 in YAC128 mice","author":"Wong","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170503081409_DDV023C17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab."},{"key":"key\n\t\t\t\t20170503081409_DDV023C18","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1523\/JNEUROSCI.6379-11.2012","article-title":"Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment","volume":"32","author":"Gafni","year":"2012","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503081409_DDV023C19","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503081409_DDV023C20","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C21","doi-asserted-by":"crossref","DOI":"10.1371\/4fd085bfc9973","article-title":"Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington's disease","author":"Landles","year":"2012","journal-title":"PLoS Curr."},{"key":"key\n\t\t\t\t20170503081409_DDV023C22","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/hmg\/dds005","article-title":"Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice","volume":"21","author":"Uribe","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","article-title":"APP binds DR6 to trigger axon pruning and neuron death via distinct caspases","volume":"457","author":"Nikolaev","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170503081409_DDV023C24","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1523\/JNEUROSCI.3356-04.2004","article-title":"Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice","volume":"24","author":"Houde","year":"2004","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503081409_DDV023C25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.cr.7310112","article-title":"Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity","volume":"16","author":"Berger","year":"2006","journal-title":"Cell Res."},{"key":"key\n\t\t\t\t20170503081409_DDV023C26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.cdd.4402044","article-title":"Broad-spectrum caspase inhibitors: from myth to reality?","volume":"14","author":"Chauvier","year":"2006","journal-title":"Cell Death Differ."},{"key":"key\n\t\t\t\t20170503081409_DDV023C27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2008.10.101","article-title":"Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity","volume":"377","author":"Pereira","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170503081409_DDV023C28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1750-1326-6-59","article-title":"Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease","volume":"6","author":"Carroll","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"key\n\t\t\t\t20170503081409_DDV023C29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","article-title":"HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain","volume":"16","author":"Kalchman","year":"1997","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170503081409_DDV023C30","doi-asserted-by":"crossref","first-page":"e27680","DOI":"10.1371\/journal.pone.0027680","article-title":"A quantitative method for the specific assessment of caspase-6 activity in cell culture","volume":"6","author":"Ehrnhoefer","year":"2011","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170503081409_DDV023C31","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1073\/pnas.1111405108","article-title":"Nanoparticles enhance brain delivery of blood\u2013brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging","volume":"108","author":"Koffie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170503081409_DDV023C32","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1152\/jn.00234.2004","article-title":"In vivo mammalian brain imaging using one- and two-photon fluorescence microendoscopy","volume":"92","author":"Jung","year":"2004","journal-title":"J. Neurophysiol."},{"key":"key\n\t\t\t\t20170503081409_DDV023C33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"key\n\t\t\t\t20170503081409_DDV023C34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nm.3246","article-title":"Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models","volume":"19","author":"Marco","year":"2013","journal-title":"Nat. Med."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/24\/9\/2604\/14147232\/ddv023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T23:17:25Z","timestamp":1566256645000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddv023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,1,23]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddv023","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,23]]}}}